Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas

European Journal of Haematology

Volumn 78, Issue 4, 2007, Pages 283-289

  Walsh, Sarah H ^a   Grabowski, Pawel ^b   Berglund, Mattias ^a   Thunberg, Ulf ^a   Thorsélius, Mia ^a   Tobin, Gerard ^a   Åleskog, Anna ^a   Karlsson, Karin ^c   Sundström, Christer ^a   Laurell, Anna ^a   Enblad, Gunilla ^a   Rosenquist, Richard ^a   Roos, Göran ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

B cell malignancy; Chronic lymphocytic leukemia; Diffuse large B cell lymphoma; Germinal center origin; Mantle cell lymphomas; Telomere length

Indexed keywords

IMMUNOGLOBULIN;

ARTICLE; B CELL LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLICULAR LYMPHOMA; GENE MUTATION; GENETIC HETEROGENEITY; HAIRY CELL LEUKEMIA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TELOMERE;

DNA MUTATIONAL ANALYSIS; GERMINAL CENTER; HUMANS; IMMUNOGLOBULINS; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERE;

EID: 33847691448     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00817.x     Document Type: Article

References (33)

1. Norrback KF, Dahlenborg K, Carlsson R, Roos G. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996;88:222-9.
2. Norrback KF, Hultdin M, Dahlenborg K, Osterman P, Carlsson R, Roos G. Telomerase regulation and telomere dynamics in germinal centers. Eur J Haematol 2001;67:309-17.
3. Weng NP, Granger L, Hodes RJ. Telomere lengthening and telomerase activation during human B cell differentiation. PNAS 1997;94: 10827-32.
4. Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular Origin of Human B-Cell Lymphomas. N Engl J Med 1999;341:1520-9.
5. Ladetto M, Compagno M, Ricca I, et al. Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders. Blood 2004;103:4644-9.
6. Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 1998;58:4918-22.
7. Damle RN, Batliwalla FM, Ghiotto F, et al. Telomere length and telomerase activity delineate distinctive replicative features of the B-CLL subgroups defined by immunoglobulin V gene mutations. Blood 2004;103:375-82.
8. Grabowski P, Hultdin M, Karlsson K, Tobin G, Aleskog A, Thunberg U, Laurell A, Sundstrom C, Rosenquist R, Roos G. Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status. Blood 2005;105:4807-12.
9. Hultdin M, Rosenquist R, Thunberg U, Tobin G, Norrback KF, Johnson A, Sundstrom C, Roos G. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications. Br J Cancer 2003;88:593-8.
10. Walsh SH, Thorselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 2003;101:4047-54.
11. Thorselius M, Walsh S, Eriksson I, Thunberg U, Johnson A, Backlin C, Enblad G, Sundstrom C, Roos G, Rosenquist R. Somatic hypermutation and VH gene usage in mantle cell lymphoma. Eur J Haematol 2002;68:217-24.
12. Kienle D, Krober A, Katzenberger T, et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003;102:3003-9.
13. Thorselius M, Walsh SH, Thunberg U, Hagberg H, Sundstrom C, Rosenquist R. Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia. Leuk Res 2005;29:153-8.
14. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002;346:1937-47.
15. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.
16. Lossos IS, Alizadeh AA, Eisen MB, Chan WC, Brown PO, Botstein D, Staudt LM, Levy R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. PNAS 2000;97:10209-13.
17. Berglund M, Thunberg U, Amini RM, et al. Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis. Mol Pathol 2005;18:1113-20.
18. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103:275-82.
19. Bahler DW, Campbell MJ, Hart S, Miller RA, Levy S, Levy R. Ig VH gene expression among human follicular lymphomas. Blood 1991;78:1561-8.
20. Bahler DW, Levy R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. PNAS 1992;89:6770-4.
21. Walsh SH, Laurell A, Sundstrom G, Roos G, Sundstrom C, Rosenquist R. Lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia derives from an extensively hypermutated B cell that lacks ongoing somatic hypermutation. Leuk Res 2005;29:729-34.
22. Sahota SS, Forconi F, Ottensmeier CH, Provan D, Oscier DG, Hamblin TJ, Stevenson FK. Typical Waldenstrom macroglobulinemia is derived from a B-cell arrested after cessation of somatic mutation but prior to isotype switch events. Blood 2002;100:1505-7.
23. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
24. Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood 2002;99:2262-4.
25. Tobin G, Thunberg U, Laurell A, et al. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome. Haematologica 2005;90:465-9.
26. Kuppers R, Zhao M, Rajewsky K, Hansmann ML. Detection of clonal B cell populations in paraffin-embedded tissues by polymerase chain reaction. Am J Pathol 1993;143:230-9.
27. Cawthon RM. Telomere measurement by quantitative PCR. Nucl Acids Res 2002;30:e47.
28. Dunn-Walters DK, Isaacson PG, Spencer J. Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells. J Exp Med 1995;182:559-66.
29. Tierens A, Delabie J, Michiels L, Vandenberghe P, De Wolf-Peeters C. Marginal-zone B cells in the human lymph node and spleen show somatic hypermutations and display clonal expansion. Blood 1999;93:226-34.
30. Weller S, Faili A, Garcia C, Braun MC, Le Deist F, de Saint Basile G, Hermine O, Fischer A, Reynaud CA, Weill JC. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. PNAS 2001;98:1166-70.
31. Weller S, Braun MC, Tan BK, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004;104:3647-54.
32. Son NH, Joyce B, Hieatt A, Chrest FJ, Yanovski J, Weng NP. Stable telomere length and telomerase expression from naive to memory B-lymphocyte differentiation. Mech Ageing Dev 2003;124:427-32.
33. Martens UM, Brass V, Sedlacek L, Pantic M, Exner C, Guo Y, Engelhardt M, Lansdorp PM, Waller CF, Lange W. Telomere maintenance in human B lymphocytes. Br J Haematol 2002;119:810-8.